Improving Communication in Older Cancer Patients and Their Caregivers
Improving Communication for Cancer Treatment: Addressing Concerns of Older Cancer Patients and Caregivers
This randomized clinical trial studies standardized geriatric assessment (GA) or usual care
in improving communication and quality of life in older patients with advanced solid tumors
or lymphoma and their caregivers. A GA measures the issues important to older patients,
including function, psychological status, cognitive abilities, social support, and the
impact of medical problems on quality of life. A GA may improve communication between
patients and their doctors in addressing patient concerns. It is not yet known whether a
standardized GA is more effective than usual care in improving communication and quality of
life in older patients with solid tumors or lymphoma.
I. To determine if providing geriatric assessment (GA) summary plus GA-driven
recommendations to patients, their caregivers and oncology physicians improves patient
satisfaction with communication with the oncology physician regarding age-related concerns.
I. To determine if providing GA summary plus GA-driven recommendations to patients, their
caregivers, and oncology physicians increases discussions about age-related issues during
II. To determine whether initially providing patients, their caregivers, and oncology
physicians with GA summary plus GA-driven recommendations prior to their treatment
influences quality of life of older patients receiving treatment and their caregivers.
III. To determine whether providing patients, their caregivers, and oncology physicians with
GA summary plus GA-driven recommendations influences caregiver satisfaction with
communication about age-related issues.
I. Evaluate whether the number of discussions about age-related issues during the clinic
visit correlates with patient satisfaction and will explore if communication about
age-related issues influences how patients, caregivers, and oncology physicians make
decisions for cancer treatment.
OUTLINE: Patients are randomized to 1 of 2 arms.
ARM I: Patients and their caregivers (if participating) complete the GA summary and receive
recommendations guided by GA results provided by the oncology team to discuss and implement
for each age-related issue at baseline.
ARM II: Patients and their caregivers (if participating) complete the GA at baseline.
After completion of study, patients are followed up at 4-6 weeks, 10-14 weeks, and 20-24
Adult Solid Neoplasm, Lymphoma
University of Rochester
Gary Morrow, National Cancer Institute (NCI), Patient-Centered Outcomes Research Institute